Market Analysis - Pharma Chem 2018
Pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is inarguable. In 2014, total pharmaceutical revenues worldwide had exceeded one trillion U.S. dollars for the first time. North America is responsible for the largest portion of these revenues, due to the leading role of the U.S. pharmaceutical industry. More than any other industry, the pharmaceutical sector is highly dependent on its research and development segment. The top pharmaceutical companies invest up to 20 percent of their revenues in R&D measures. The United States is a traditional stronghold of pharmaceutical innovation.
Global pharmaceutical growth
Recent research projects that Global growth rate for the pharma industry of 6.3% CAGR through 2022, up from the 5% CAGR it predicted last year for the 2014-2020 period.,which is evaluated. The overall $1.12 trillion market in 2022, says Evaluate, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expirations take hold. (Evaluate says that the global market actually declined by 1.0% in 2015, but will grow by 4.8% in 2016. Prescription sales excluding generics will rise 4.4% this year, and will reach $1.006 trillion in 2022. During the 2008-2015 period, the compound annual growth rate of global R&D spending was 1.7%; during the 2016-2022 period, the rate will grow at 2.8%. The year-over-year increase, however, will remain around 3%, versus some dramatic jumps seen in 2013, 2014 and 2015. Overall spending will reach $182 billion in 2022.Research firm says that world wide drug sales increases year by year.The below figure represents the world wide prescription drug sales.
Health Care Expenditure Report :
Health care expenditure in the OECD varies substantially over time and across countries. From 1970 to 2004, per capita health expenditure has increased markedly in the OECD with an annual average rate of 11.5 per cent. Such temporal dynamic has been characterized by large di§erences across countries, leading to marked geographical heterogeneity in the level of spending. For example, a snapshot in 2004 shows that the US, with an average of $6,0372 , has the highest amount of health expenditure, followed by Switzerland ($4,045), France ($4,103), and Germany ($3,169). As a share of Gross Domestic Product (GDP), health care spending in the OECD has almost doubled over this period, increasing from 4.9 per cent in 1970 to 8.8 per cent in 2004. In 2014 health care expenditures increased to 17.4% The increase is largely because of expanded health coverage under the ACA and greater use of health care services.
Pharma Chem 2018 invites professional pharmaceutical scientists, pharmacists, researchers, professors, scientific communities, delegates, students, business professionals and executives from all over the world to attend the “ 21st International Conference on Pharmaceutical Chemistry” scheduled during Oct 31- Nov01, 2018 at San Francisco, USA.
This scientific conference enables every speaker to gather all the novel innovations and developmental techniques on pharmaceutical chemistry and Advanced organic chemisty. This conference could be a global platform for sharing and exploring new areas of research and development and also to the raising technologies in the field of Pharmaceutical chemistry. It provides a professional area to discuss, present and learn about Chemical biology, Computational chemistry, Clinical Pharmacy, Pharmaceutical Engineering, Drug design and development, Analytical Chemistry, Pharmacokinetics and Pharmacodynamics, Analytical Pharmacognocy, Pharmaceutical Biotechnology, Pharmaceutical Industry, Physical Pharmacy, Emerging oncology drugs in pharma, Drug Delivery Techniques, Pharmaceutical Biochemistry.